Literature DB >> 8453184

Treatment recommendations for respiratory tract infections associated with aging.

R A Fox1.   

Abstract

Age-related changes, for example reduced elasticity and earlier airways collapse, predispose the elderly to respiratory infection. Other factors such as a lifetime of smoking, the use of hypnotics, or the development of stroke also predispose. Pneumonia becomes increasingly common with advancing age, and both morbidity and mortality increase with associated disease burden. Diagnosis of pneumonia may be more difficult in the aged because of physiological changes. However, careful physical examination with accurate, regular recording of body temperature will usually reveal the characteristic features of pneumonia, which should be confirmed by chest radiograph. In the frail elderly, the onset of impaired function, such as confusion, immobility, falling or incontinence, should raise suspicion of infection. Pneumonia is classified as community-acquired, nursing home-acquired or nosocomial, which helps in the empirical choice of antibiotics. Streptococcus pneumoniae is the most common organism in the community, then Haemophilus influenzae and Branhamella catarrhalis. Gram-negative organisms like Klebsiella and Escherichia coli are more common in nosocomial infections. Nursing home patients with pneumonia tend to be more frail than those in the community. Treatment is directed at eradication of the organism with the appropriate antibiotic, maintaining hydration and oxygenation, as well as managing impaired mobility, faecal loading, urinary incontinence and confusion. Influenza vaccination is strongly recommended for the frail elderly. Tuberculosis remains an important diagnosis in the frail elderly and should always be considered, especially in patients with respiratory infection who fail to respond to conventional therapy.

Entities:  

Mesh:

Year:  1993        PMID: 8453184     DOI: 10.2165/00002512-199303010-00004

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  18 in total

1.  The atypical presentation of infection in old age.

Authors:  P Berman; D B Hogan; R A Fox
Journal:  Age Ageing       Date:  1987-07       Impact factor: 10.668

2.  Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates.

Authors:  R W Geckler; D H Gremillion; C K McAllister; C Ellenbogen
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

Review 3.  Pneumococcal vaccine in the institutionalized elderly: review of past and recent studies.

Authors:  D W Bentley
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

4.  Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.

Authors:  F A Khan; R Basir
Journal:  Chest       Date:  1989-09       Impact factor: 9.410

5.  Methods to assess the quality of care for elderly patients with pneumonia.

Authors:  R W Dubois
Journal:  Semin Respir Infect       Date:  1990-12

6.  [Branhamella catarrhalis respiratory tract infections].

Authors:  S Letonja; E Music; M Kumelj
Journal:  Plucne Bolesti       Date:  1990 Jul-Dec

7.  Community-acquired pneumonia requiring hospitalization. Is it different in the elderly?

Authors:  T J Marrie; E V Haldane; R S Faulkner; H Durant; C Kwan
Journal:  J Am Geriatr Soc       Date:  1985-10       Impact factor: 5.562

8.  Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged.

Authors:  W M Valenti; R G Trudell; D W Bentley
Journal:  N Engl J Med       Date:  1978-05-18       Impact factor: 91.245

9.  Pyrexia in infection in the elderly.

Authors:  C H McAlpine; B J Martin; I M Lennox; M A Roberts
Journal:  Age Ageing       Date:  1986-07       Impact factor: 10.668

10.  Tuberculosis among elderly persons: an outbreak in a nursing home.

Authors:  W W Stead
Journal:  Ann Intern Med       Date:  1981-05       Impact factor: 25.391

View more
  6 in total

Review 1.  Nursing home-acquired pneumonia. Treatment options.

Authors:  T J Marrie; K L Slayter
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

Review 2.  Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.

Authors:  H D Langtry; R N Brogden
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.

Authors:  C J Dunn; L B Barradell
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

Review 4.  Physiological changes due to age. Implications for respiratory drug therapy.

Authors:  J F Morris
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

5.  Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia.

Authors:  Emil Ekbom; Jennifer Quint; Linus Schöler; Andrei Malinovschi; Karl Franklin; Mathias Holm; Kjell Torén; Eva Lindberg; Deborah Jarvis; Christer Janson
Journal:  BMC Pulm Med       Date:  2019-12-19       Impact factor: 3.317

Review 6.  Drug therapy in haemodialysis patients. Special considerations in the elderly.

Authors:  W L St Peter; J L Clark; O M Levos
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 4.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.